However, no vaccine offers complete protection. Some vaccinated people, especially those who are older or have significant underlying health conditions, can still become seriously ill. This is why healthcare professionals consider individual risk factors when discussing vaccination and other preventive measures.
The figures shown in the supplied article, including estimates of reduced hospitalization and emergency-care visits, should be interpreted in context. Effectiveness estimates depend on the study population, the period studied, the circulating variants, the vaccine formulation, and the comparison group. A percentage from one study should not be treated as a universal figure for every person or every season.
For the most accurate picture, readers should look for current data from public-health authorities and studies that clearly explain how effectiveness was measured.
What About Updated Vaccines and New Variants?
The virus that causes COVID-19 continues to evolve. Changes in its genetic material can affect how efficiently it spreads and how well existing immune responses recognize it.
Vaccine formulations may therefore be updated to better match variants expected to circulate. The goal is to improve protection against the strains that are most relevant at a particular time, especially with respect to severe illness.
An updated vaccine does not necessarily prevent every infection caused by a newer variant. Instead, its value must be assessed through evidence about immune responses and real-world outcomes.
Recommendations can also differ by country and population. Health authorities may consider age, medical vulnerability, previous vaccination, prior infection, and the time elapsed since the last dose when determining who should receive an updated vaccine.
People who are unsure whether they need another dose should consult current guidance from their local public-health authority or a qualified healthcare professional. Advice intended for older adults or people with weakened immune systems may differ from recommendations for younger, healthy adults.
It is also worth remembering that vaccine protection is only one part of respiratory-virus prevention. Staying home when ill, improving indoor ventilation, and using a well-fitting mask in appropriate high-risk settings can help reduce exposure and transmission.
Understanding the Safety Profile
COVID-19 vaccines have been extensively studied and monitored, and the safety profile of authorized vaccines is continually evaluated as new information becomes available.
Most reported side effects are mild to moderate and temporary. Common reactions include soreness at the injection site, fatigue, headache, muscle aches, chills, and a short-lived fever. These symptoms generally reflect the body's response to vaccination and usually improve within a few days.
Serious adverse events can occur, but they are uncommon. Specific rare risks have been identified with certain vaccine types, and the details can differ by age, sex, product, and medical history. For example, myocarditis and pericarditis—inflammation involving the heart muscle or surrounding tissue—have been reported rarely after some mRNA COVID-19 vaccines, particularly in adolescent and young adult males. The risk and clinical significance should be discussed in the context of the individual's circumstances and the benefits of vaccination.
Severe allergic reactions are also possible but rare. Anyone who develops difficulty breathing, swelling of the throat, or other signs of a serious allergic reaction after vaccination needs emergency medical care.